| Original language | English |
|---|---|
| Pages (from-to) | 233-236.e3 |
| Journal | Journal of Allergy and Clinical Immunology |
| Volume | 134 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jul 2014 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of Allergy and Clinical Immunology, Vol. 134, No. 1, 07.2014, p. 233-236.e3.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase δ syndrome
AU - Kracker, Sven
AU - Curtis, James
AU - Ibrahim, Mohammad A.A.
AU - Sediva, Anna
AU - Salisbury, Jon
AU - Campr, Vit
AU - Debré, Marianne
AU - Edgar, J. David M.
AU - Imai, Kohsuke
AU - Picard, Capucine
AU - Casanova, Jean Laurent
AU - Fischer, Alain
AU - Nejentsev, Sergey
AU - Durandy, Anne
N1 - Funding Information: S.K. is a Centre National de la Recherche Scientifique (CNRS) researcher. A.D., A.F., and S.K. are funded by Institut National de la Santé et de la Recherche Médicale . S.K. is supported by Fondation pour la Recherche Médicale (FRM: ING20130526624 ). A.D. is supported by the EUFP7 EUROPAD contract 201549 , Association Contre Le Cancer , and the l'Agence Nationale de la Recherche (grant no. 2010-CSRD ). A.F. is supported by the EUFP7 ERC PIDIMMUNE (grant no. 249816 ). S.N. is a Wellcome Trust Senior Research Fellow in Basic Biomedical Science (095198/Z/10/Z). S.N. is also supported by the European Research Council Starting grant 260477 and the EU FP7 collaborative grant 261441 (PEVNET project). Funding Information: Disclosure of potential conflict of interest: J.-L. Casanova has received research support from the National Institutes of Health , the St Giles Foundation , Merck , BiogenIdec , and Pfizer and has had consultant arrangements with Pfizer, GlaxoSmithKline, NovImmune, BiogenIdec, Merck, and Sanofi. A. Fischer has received research support from INSERM and the European Union 7th Framework Programme ERC PIDIMMUNE . S. Nejentsev has received research support from the Wellcome Trust , the European Research Council , and the European Union 7th Framework Programme . A. Durandy has received research support from the European Union 7th Framework Programme EUROPAD , l'Agence Nationale de la Recherche (ANR) , and l'Association de la Recherche contre le Cancer (ARC) . The rest of the authors declare that they have no relevant conflicts of interest. Copyright: Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2014/7
Y1 - 2014/7
UR - http://www.scopus.com/inward/record.url?scp=84903746318&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2014.02.020
DO - 10.1016/j.jaci.2014.02.020
M3 - Article
C2 - 24698326
AN - SCOPUS:84903746318
SN - 0091-6749
VL - 134
SP - 233-236.e3
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 1
ER -